Panel Votes For Removing Nebulizer, Asthma Ingredients From Monograph
This article was originally published in The Tan Sheet
Executive Summary
The Nonprescription Drugs Advisory Committee voted 15-5 to recommend FDA remove epinephrine and racepinephrine delivered by a hand-held rubber bulb nebulizer for the relief of mild intermittent asthma from the OTC monograph. Members said their vote was conflicted because of public health concerns and an ongoing enforcement action related to the monograph.